Clinical Research Directory
Browse clinical research sites, groups, and studies.
IDUS in CBD Stone Recurrence High Risk Patients
Sponsor: Shanghai Municipal Hospital of Traditional Chinese Medicine
Summary
This study is designed to observed CBD stones cases with high recurrence risks applying IDUS or not during ERCP. Patients with CBD stone high recurrence risks were enrolled in this study, and prospectively randomized into IUDS group and control group during lithotomy. Operation time, radiation time, hospitalization cost, retain of nasobiliary tube, deployment of stent were recorded. Symptoms and conditions after ERCP were also followed up including blood amylase, routine blood test, abdominal pain, post-ERCP pancreatitis, resection of gallbladder, recurrence of CBD stone and onset of cholangitis.
Official title: Practical Value of IDUS in Patients With High Risk of Recurrence of Common Bile Duct Stones After ERCP Lithotomy
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
248
Start Date
2021-11-02
Completion Date
2026-04-16
Last Updated
2026-04-20
Healthy Volunteers
No
Interventions
IDUS examination
for patients with high risks of bile duct stones recurrence using IDUS during ERCP
Locations (1)
Shang General Hospital
Shanghai, China